Drugmaker Eli Lilly announces new plant in Pennsylvania as part of broader domestic expansion

5 days ago 11

Associated Press Finance

Updated Fri, January 30, 2026 astatine 11:24 AM CST 1 min read

HARRISBURG, Pa. (AP) — Drugmaker Eli Lilly and Co. (LLY) said Friday that it volition physique a $3.5 cardinal manufacturing installation successful Pennsylvania, arsenic the institution expands home accumulation and capitalizes connected surging income of obesity and diabetes treatments.

Indianapolis-based Eli Lilly, shaper of weight-loss attraction Zepbound and diabetes cause Mounjaro, is successful the midst of a broader home enlargement that includes caller plants it has announced successful Texas, Virginia and Alabama. Another installation is nether operation successful Indiana.

NYSE - Nasdaq Real Time Price USD

1,040.14 +16.62 (+1.62%)

As of 12:29:58 PM EST. Market Open.

The institution said the caller works successful Fogelsville, conscionable extracurricular Allentown, volition marque injectable drugs and devices, including producing weight-loss cause retatrutide, a once-a-week injectable cause that is inactive being studied and not disposable for nationalist use.

Construction was expected to statesman this twelvemonth and decorativeness successful 2031, it said.

Sales of Zepbound and Mounjaro boosted the company's third-quarter nett to a grounds $5.58 billion. Third-quarter gross was $17.6 billion, up much than 50% from the aforesaid 4th a twelvemonth earlier. Zepbound and Mounjaro unsocial accounted for $10 cardinal successful income successful the company's 3rd quarter.